| 发明名称 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | ||
| 摘要 | Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active. | ||
| 申请公布号 | US8921350(B2) | 申请公布日期 | 2014.12.30 |
| 申请号 | US201313743166 | 申请日期 | 2013.01.16 |
| 申请人 | CymaBay Therapeutics, Inc. | 发明人 | Chen Xin;Cheng Peng;Clemens L. Edward;Johnson Jeffrey D.;Ma Jingyuan;Murphy Alison;Nashashibi Imad;Rabbat Christopher J.;Song Jiangao;Wilson Maria E.;Zhu Yan;Zhao Zuchun |
| 分类号 | A61K31/33;C07D413/04;C07D417/14;C07D413/14;C07D401/04;C07D417/04;C07D401/14 | 主分类号 | A61K31/33 |
| 代理机构 | Foley & Lardner LLP | 代理人 | Foley & Lardner LLP |
| 主权项 | 1. A compound selected from the group consisting of:or a salt thereof. | ||
| 地址 | Newark CA US | ||